HNF4α is also an effective circadian tumor suppressor, in particular its main isoform expressed in the adult liver (P1-HNF4α), whereas a different promoter driven isoform (P2-HNF4α) suppresses ARNTL and is expressed in HNF4α-positive HCC [60]. This evidence concerns the gene HNF4A and hepatocellular carcinoma.